KIM PETER S
Known title: DirectorCIK: 0001181180
KIM PETER S's purchase track record
How the stock did after each of KIM PETER S's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
4
of 4 since March 19, 2024
Stock higher 6 months later
100%
3 months: 50%
Median 6-month return
+17.2%
3 months: +6.3%
Beat the S&P 500
100%
median +8.1% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 5/8/2024 | TRDA | $428K | -1.7% | +32.8% | +14.3% |
| 4/8/2024 | TRDA | $35K | +12.6% | +23.0% | +9.5% |
| 3/28/2024 | TRDA | $21K | 0.0% | +11.3% | +9.3% |
| 3/19/2024 | TRDA | $158K | +16.5% | +11.5% | +8.8% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| TRDA | ▲ Buy | Option Exercise | 11,918 | $72K | 6/3/2024 | View on chart |
| TRDA | ▲ Buy | Open Market | 25,000 | $365K | 5/14/2024 | View on chart |
| TRDA | ▲ Buy | Open Market | 2,200 | $31K | 5/9/2024 | View on chart |
| TRDA | ▲ Buy | Open Market | 2,276 | $32K | 5/8/2024 | View on chart |
| TRDA | ▲ Buy | Open Market | 2,600 | $35K | 4/8/2024 | View on chart |
| TRDA | ▲ Buy | Open Market | 1,512 | $21K | 3/28/2024 | View on chart |
| TRDA | ▲ Buy | Open Market | 2,750 | $38K | 3/26/2024 | View on chart |
| TRDA | ▲ Buy | Open Market | 3,180 | $42K | 3/25/2024 | View on chart |
| TRDA | ▲ Buy | Open Market | 3,118 | $43K | 3/22/2024 | View on chart |
| TRDA | ▲ Buy | Open Market | 704 | $9K | 3/21/2024 | View on chart |
| TRDA | ▲ Buy | Open Market | 1,128 | $14K | 3/20/2024 | View on chart |
| TRDA | ▲ Buy | Open Market | 900 | $11K | 3/19/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
TRDA sees institutional interest from NVIDIA and Merck
The Benzinga report notes that institutional investors linked to NVIDIA and Merck have increased their positions in TRDA. This activity signals growing confidence in the company’s pipeline and may attract additional attention from other investors. The move comes as TRDA trades near the lower end of its 52‑week range, providing a potential entry point for those monitoring the stock.
TRDA sees institutional interest from NVIDIA and Merck. The Benzinga report notes that institutional investors linked to NVIDIA and Merck have increased their positions in TRDA. This activity signals growing confidence in the company’s pipeline and may attract additional attention from other investors. The move comes as TRDA trades near the lower end of its 52‑week range, providing a potential entry point for those monitoring the stock.